BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata

Two closely related beta-lactamases, BRO-1 and BRO-2 (formerly called Ravasio and 1908), are found in Moraxella (Branhamella) catarrhalis. We screened strains of B. catarrhalis recovered in the United States since 1952 and identified the first beta-lactamase-positive isolate in August 1976. The prevalence of the enzymes among 394 clinical isolates from one Texas hospital has averaged 75% since testing began in 1983. Screening of isolates of Moraxella subgenus Moraxella revealed the BRO enzymes in two other human respiratory tract species, M. lacunata and M. nonliquefaciens, beginning in 1978. A different beta-lactamase with a pI of 6.4 predominated in other species of subgenus Moraxella. BRO-2 had a different isoelectric focusing pattern and was produced in lesser amounts than BRO-1, but the two enzymes were indistinguishable by substrate or inhibitor profile. BRO enzymes from B. catarrhalis, M. nonliquefaciens, and M. lacunata could be transferred by conjugation and, for B. catarrhalis, also by transformation to B. catarrhalis. Plasmid bands were demonstrated in 90% of M. nonliquefaciens and in one previously reported strain of B. catarrhalis, but no change in plasmid profiles was seen in beta-lactamase-positive recombinants, supporting previous studies that suggested the beta-lactamase genes are chromosomal.

[1]  R. Sykes,et al.  PATHOGENICITY OF AND β-LACTAMASE PRODUCTION BY BRANHAMELLA (NEISSERIA) CATARRHALIS , 1977, The Lancet.

[2]  A. Seaton,et al.  Bronchopulmonary infection due to Branhamella catarrhalis. , 1983, British medical journal.

[3]  C. Thornsberry,et al.  Transfer of Beta-Lactamase Genes of Neisseria gonorrhoeae by Conjugation , 1977, Antimicrobial Agents and Chemotherapy.

[4]  K. Bøvre.  Oxidase positive bacteria in the human nose incidence and species distribution, as diagnosed by genetic transformation. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[5]  R. Wallace,,et al.  Branhamella catarrhalis as a lower respiratory tract pathogen in patients with chronic lung disease. , 1986, Archives of internal medicine.

[6]  J. Butzler,et al.  Isolation of penicillin and streptomycin resistant strains of Moraxella osloensis. , 2009, Acta pathologica et microbiologica Scandinavica. Section B: Microbiology and immunology.

[7]  G. Doern,et al.  Antibiotic Susceptibility of Beta-Lactamase-Producing Strains of Branhamella (Neisseria) catarrhalis , 1980, Antimicrobial Agents and Chemotherapy.

[8]  S. D. Henriksen.  Moraxella, Acinetobacter, and the Mimeae. , 1973, Bacteriological reviews.

[9]  C. W. Moss,et al.  Cultural and chemical characterization of CDC groups EO-2, M-5, and M-6, Moraxella (Moraxella) species, Oligella urethralis, Acinetobacter species, and Psychrobacter immobilis , 1988, Journal of clinical microbiology.

[10]  R. Wallace,,et al.  Characterization of beta-lactamases in Mycobacterium fortuitum including a role in beta-lactam resistance and evidence of partial inducibility. , 1986, The American review of respiratory disease.

[11]  P. Thornley,et al.  CLINICAL AND MICROBIOLOGICAL FEATURES OF BRANHAMELLA CATARRHALIS BRONCHOPULMONARY INFECTIONS , 1984, The Lancet.

[12]  B. Catlin.  Transfer of the Organism Named Neisseria Catarrhalis to Branhamella Gen. Nov , 1970 .

[13]  P. K. Smith,et al.  Measurement of protein using bicinchoninic acid. , 1985, Analytical biochemistry.

[14]  T. J. Mcdonald,et al.  Plasmid profiles of Moraxella bovis isolates. , 1986, American journal of veterinary research.

[15]  C. Kamme,et al.  Intrageneric and Intergeneric Transfer of Branhamella catarrhalis β-Lactamase Production , 1984 .

[16]  C. Kamme,et al.  Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity. , 1985, The Journal of antimicrobial chemotherapy.

[17]  G. V. Van Hare,et al.  Emergence of beta-lactamase-producing strains of Branhamella catarrhalis as important agents of acute otitis media. , 1983, Pediatric infectious disease.

[18]  C. Reading,et al.  beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid , 1982, Antimicrobial Agents and Chemotherapy.

[19]  L. Freundlich,et al.  In vitro antibiotic sensitivity of Moraxella species. , 1978, Chemotherapy.

[20]  G. V. Van Hare,et al.  Acute otitis media caused by Branhamella catarrhalis: biology and therapy. , 1987, Reviews of infectious diseases.

[21]  P. Sparling,et al.  High-frequency conjugal transfer of a gonococcal penicillinase plasmid , 1980, Journal of bacteriology.

[22]  S. Lapage,et al.  Identification and characterization of Moraxella phenylpyruvica , 1972, Journal of clinical pathology.

[23]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[24]  A. Labidi.  Restriction endonuclease analysis of total deoxyribonucleic acid of Mycobacterium tuberculosis H37RV (ATCC 27294) and of M. bovis (ATCC 19210). , 1988, Archives de l'Institut Pasteur de Tunis.

[25]  S. Bhaduri,et al.  Simple and rapid method for disruption of bacteria for protein studies , 1983, Applied and environmental microbiology.

[26]  D. Towle,et al.  Evaluation of the rapid penicillinase paper strip test for detection of beta-lactamase , 1982, Journal of clinical microbiology.

[27]  R. Wallace,,et al.  Disk diffusion susceptibility of Branhamella catarrhalis and relationship of beta-lactam zone size to beta-lactamase production , 1986, Antimicrobial Agents and Chemotherapy.

[28]  K. Bush,et al.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b' , 1989, Antimicrobial Agents and Chemotherapy.

[29]  C. Kamme,et al.  Transfer of β-Lactamase Production in Branhamella catarrhalis , 1983 .

[30]  M. Jones,et al.  In vitro susceptibilities and beta-lactamase production of 53 clinical isolates of Branhamella catarrhalis , 1985, Antimicrobial Agents and Chemotherapy.

[31]  B. Eisenstein,et al.  Conjugal transfer of the gonococcal penicillinase plasmid. , 1977, Science.

[32]  I. Simpson,et al.  The origin and properties of beta-lactamase satellite bands seen in isoelectric focusing. , 1983, The Journal of antimicrobial chemotherapy.

[33]  C Reading,et al.  Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus , 1977, Antimicrobial Agents and Chemotherapy.

[34]  P. H. Roy,et al.  Characterization of a plasmid isolated from Branhamella catarrhalis and detection of plasmid sequences within the genome of a B. catarrhalis strain. , 1988, Plasmid.

[35]  G. Milmoe,et al.  Acute maxillary sinusitis in children. , 1981, The New England journal of medicine.

[36]  J. Johnsson,et al.  In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis. , 1977, The Journal of antimicrobial chemotherapy.

[37]  M. Richmond,et al.  A comparative study of eight distinct beta-lactamases synthesized by gram-negative bacteria. , 1970, Journal of general microbiology.

[38]  K. Kersters,et al.  Oligella, a New Genus Including Oligella urethralis comb. nov. (Formerly Moraxella urethralis) and Oligella ureolytica sp. nov. (Formerly CDC Group IVe): Relationship to Taylorella equigenitalis and Related Taxa , 1987 .

[39]  S. D. Henriksen.  Moraxella duplex var. nonliquefaciens, habitat and antibiotic sensitivity. , 2009, Acta pathologica et microbiologica Scandinavica.

[40]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[41]  K. Bush.  Methodology for the Study of P-Lactamases , 2022 .

[42]  C. P. V. Boven,et al.  Branhamella catarrhalis: antibiotic sensitivities and β-lactamases , 1984 .

[43]  H. F. Troutt,et al.  Genotypic, phenotypic, and biological characteristics of Moraxella bovis. , 1984, American journal of veterinary research.